RE:RE:RE:RE:RE:A Mickey Mouse Deal / CoQ10 Deal?Agreed it would not have been 2 bil
but still substantiel say close to 1 b
significant value creation for investors
That's what the biopharma start ups should be aiming for
creating good value - they can always be more but investors have the opportunity to invest in all sections of the value chain if so wish
its not for a start up to try and cover the whole value chain of a concept